NCT06415162

Brief Summary

This study was planned to evaluate the effect of education on the management of side effects and the use of cooling pillowcase on hot flush complaints, sleep and quality of life in women with breast cancer receiving hormone therapy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 19, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 10, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 16, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2024

Completed
Last Updated

May 16, 2024

Status Verified

May 1, 2024

Enrollment Period

8 months

First QC Date

May 10, 2024

Last Update Submit

May 10, 2024

Conditions

Keywords

Hormone therapyBreast cancerCooling pillowcaseHot flashesQuality of life

Outcome Measures

Primary Outcomes (1)

  • Menopausal Hot Flush Scale

    All items in the scale are evaluated between '0' and '10' points. The highest score that can be obtained from the scale is '100' and the lowest score is '0'. The higher the score obtained from the scale, the higher the woman's level of being affected by hot flushes.

    nine weeks

Secondary Outcomes (2)

  • The Pittsburgh Sleep Quality Index

    nine weeks

  • Functional Assessment Of Cancer Therapy-Breast (FACT-B)

    nine weeks

Study Arms (2)

Cooling Pillowcases

EXPERIMENTAL

The intervention group will be given 'Patient Information Form, Menopause Specific Hot Flash Scale, Pittsburgh Sleep Quality Index and FACT-B Quality of Life Scale' to be filled in the 1st week, training on treatment side effects, training booklet and 'Hot Flash Diary' to record the hot flashes they experience. A cooling pillowcase will be given and its use will be explained. In the 5th week, 'Practices for Coping with the Side Effects of Hormone Therapy Form' will be filled out to evaluate the training given and the training will be repeated. A total of 3 follow-ups will be carried out by using the 'Patient Follow-up Form' by telephone in the 3rd and 7th weeks and face-to-face interview in the 5th week. In the 9th week, 'Menopause Specific Hot Flush Scale, Pittsburgh Sleep Quality Index and FACT-B Quality of Life Scale' and 'Practices for Coping with Side Effects of Hormone Therapy Form' will be completed to evaluate the effectiveness of the retraining given in the 5th week.

Other: Cooling Pillowcases

Control Group

NO INTERVENTION

No intervention will be given to the patients in the control group.

Interventions

No intervention will be given to the patients in the control group.

Also known as: Control group
Cooling Pillowcases

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older,
  • Estrogen and progesterone receptor positive, stage 1, 2, 3 or 4 primary breast cancer,
  • Receiving hormone therapy (goserelin acetate subcutaneously every 4 weeks),
  • Pre/Perimenopausal period,
  • No sensory and emotional barriers to communication,
  • Understands Turkish, can read and write,
  • Patients who voluntarily agreed to participate in the study.

You may not qualify if:

  • Receiving treatment for anxiety and/or depression,
  • Receiving gabapentin treatment for neuropathic pain,
  • Active viral or bacterial infection,
  • Patients with a history of sleep disorders diagnosed before hormone therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Science

Istanbul, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Breast NeoplasmsHot Flashes

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Basak Turkmen, Msc.

    University of Health science

    PRINCIPAL INVESTIGATOR
  • Semiha Akin Eroglu, Prof.

    University of Health science

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Semiha Akin Eroglu, Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The intervention group will fill in the 'Patient Information Form, Menopause Specific Hot Flash Scale, Pittsburgh Sleep Quality Index and FACT-B Quality of Life Scale' in the 1st week and will be given training on treatment side effects, training booklet and 'Hot Flash Diary' to record their hot flashes. The use of cooling pillowcase will be explained. In the 5th week, 'Practices for Coping with the Side Effects of Hormone Therapy Form' will be filled out to evaluate the training and the training will be repeated. In the 3rd and 7th weeks, 'Patient Follow-up Form' will be filled by telephone, and in the 5th week face to face. In the 9th week, 'Menopause Specific Hot Flush Scale, Pittsburgh Sleep Quality Index and FACT-B Quality of Life Scale' and 'Practices Form for Coping with Side Effects of Hormone Therapy' will be completed to evaluate the training given in the 5th week. The routine care and treatment of the control group will be continued.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Phd Student Internal Medicine Nursing

Study Record Dates

First Submitted

May 10, 2024

First Posted

May 16, 2024

Study Start

December 19, 2023

Primary Completion

July 31, 2024

Study Completion

July 31, 2024

Last Updated

May 16, 2024

Record last verified: 2024-05

Locations